SRLS Seracare Life Sciences (MM)

Copies to:
John D. Hancock, Esq.
Foley Hoag LLP
155 Seaport Boulevard
Boston, MA 02210
(617) 832-1000

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

DEREGISTRATION OF COMMON STOCK

On March 13, 2009, the Registrant filed with the Securities and Exchange Commission a registration statement on Form S-8, Registration No. 333-157933 (the “Registration Statement”), for the sale of 1,500,000 shares of the common stock (the “Common Stock”), par value $.001 per share, of the Registrant under the Registrant’s 2009 Equity Incentive Plan.

On April 20, 2012, pursuant to the terms of the Agreement and Plan of Merger, dated as of February 12, 2012, as amended by Amendment No. 1 to Agreement and Plan of Merger, dated as of February 27, 2012, by and among the Registrant, Project Plasma Holdings Corporation and Project Plasma Merger Corp., a wholly owned subsidiary of Project Plasma Holdings Corporation, Project Plasma Merger Corp. merged with and into the Registrant, and the Registrant became a wholly owned subsidiary of Project Plasma Holdings Corporation (the “Merger”). As a result of the Merger, the offering pursuant to the Registration Statement has been terminated. In accordance with an undertaking made by the Registrant in the Registration Statement to remove from registration, by means of a post-effective amendment, any of the shares of Common Stock registered under the Registration Statement that remain unsold at the termination of the offering, the Registrant hereby removes from registration the shares of Common Stock registered but unsold under the Registration Statement.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Milford, The Commonwealth of Massachusetts, on this 20th day of April, 2012.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities and on the dates indicated below.

Seracare Life Sciences (NASDAQ:SRLS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024

Seracare Life Sciences (NASDAQ:SRLS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024